Outcomes of Programmed Cell Death Protein 1 (PD-1) and Programmed Death-Ligand 1(PD-L1) Inhibitor Therapy in HIV Patients with Advanced Cancer

Due to HAART and consequent decline in mortality from infectious complications, HIV patients have an increasing burden of non-AIDS defining cancers. Data on their safety and efficacy is unknown as these patients were excluded from clinical trials due to concern of unforeseen side effects. Objectives...

Descripción completa

Detalles Bibliográficos
Autores principales: Bari, Shahla, Muzaffar, Jameel, Chan, Austin, Jain, Sanjay R., Haider, Ahmad M., Adams Curry, Marjorie, Hostler, Christopher J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582789/
https://www.ncbi.nlm.nih.gov/pubmed/31275380
http://dx.doi.org/10.1155/2019/2989048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6582789/
https://www.ncbi.nlm.nih.gov/pubmed/31275380
http://dx.doi.org/10.1155/2019/2989048

Ejemplares similares